AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Update

AstraZeneca PLC (OTCMKTS:AZNCF) saw a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 42,200 shares, an increase of 13.7% from the October 15th total of 37,100 shares. Based on an average trading volume of 2,500 shares, the days-to-cover ratio is currently 16.9 days.

Institutional Trading of AstraZeneca

A hedge fund recently bought a new stake in AstraZeneca stock. Kennedy Capital Management LLC bought a new stake in shares of AstraZeneca PLC (OTCMKTS:AZNCF) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 37,554 shares of the company’s stock, valued at approximately $5,068,000. 40.87% of the stock is currently owned by institutional investors.

AstraZeneca Price Performance

AstraZeneca stock opened at $127.96 on Friday. AstraZeneca has a 12-month low of $118.16 and a 12-month high of $175.00. The firm has a 50 day moving average of $148.69 and a 200 day moving average of $155.24.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.